DxM MicroScan WalkAway System
The DxM MicroScan WalkAway system delivers trusted detection of emerging and critical antimicrobial resistance with gold-standard1 MIC accuracy and is designed for ease of use, streamlined workflow and enhanced performance. The DxM MicroScan WalkAway system continues the innovation of quality products you have trusted for 40 years, enabling laboratories to optimize patient care while reducing the risks, costs and operational burden of emerging antimicrobial resistance.
1Kalorama United States Market for In Vitro Diagnostic Tests, 2017, pg. 878.
2Bulik CC et al. J Clin Microbiol. 2010 July; 48(7): 2402–2406.
3Anderson KF et al. J Clin Microbiol. 2007 August; 45(8): 2723–2725.
4Woodford N et al. J Clin Microbiol. 2010 August; 48(8): 2999–3002.
5The assessment of clinically significant limitations is based upon a tabulation of CLSI Group A and B test and report recommendations published in the M100 guidance documents (excluding species with natural resistance) and 1st and 2nd drugs of choice published in The Medical Letter‘s Handbook of Antimicrobial Therapy, compared with the related FDA 510K summaries, device manufacturer‘s package inserts and product recall information. M100-S17, 2017.
6ServiceTrak Clinical Executive Summary Report for ID/AST Systems, 2016.
WASP is a registered trademark or trademark of Copan Italia SpA.
MALDI Biotyper is the property of Bruker Daltonik GmbH.
Prompt is a registered trademark of 3M.